Medicare to offer up to $500 yearly for hemp CBD to seniors and veterans starting April 2026.

In April 2026, Medicare will launch a pilot program offering up to $500 annually to beneficiaries for hemp-derived CBD products, following a 2025 executive order. The initiative, led by CMS Administrator Mehmet Oz, aims to expand access for seniors and veterans managing chronic pain, sleep issues, and anxiety. While supporters highlight potential opioid reduction and real-world data benefits, critics warn the move could undermine FDA drug approval standards, citing risks from inconsistent potency, contamination, and lack of clinical validation. The program raises concerns about fairness to pharmaceutical companies developing FDA-approved cannabinoid therapies and may create conflicts with state laws and federal regulatory authority.